Variant report

Variant	nsv569425
Chromosome Location	chr15:53001538-53038488
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr15:53025336-53025762	HepG2	liver:	n/a	n/a
2	ARID3A	chr15:53001404-53001641	HepG2	liver:	n/a	n/a
3	ARID3A	chr15:53027711-53028005	HepG2	liver:	n/a	n/a
4	ATF2	chr15:53037328-53038131	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF3	chr15:53027706-53027979	K562	blood:	n/a	n/a
6	BACH1	chr15:53037389-53038150	H1-hESC	embryonic stem cell:	n/a	n/a
7	BATF	chr15:53027744-53028040	GM12878	blood:	n/a	chr15:53027945-53027954
8	BHLHE40	chr15:53027714-53028030	K562	blood:	n/a	n/a
9	BHLHE40	chr15:53022151-53022783	GM12878	blood:	n/a	chr15:53022550-53022559 chr15:53022550-53022559
10	BHLHE40	chr15:53022405-53022675	HepG2	liver:	n/a	chr15:53022550-53022559 chr15:53022550-53022559
11	BHLHE40	chr15:53022411-53022779	K562	blood:	n/a	chr15:53022550-53022559 chr15:53022550-53022559
12	BHLHE40	chr15:53027701-53028165	GM12878	blood:	n/a	n/a
13	BRCA1	chr15:53021054-53021493	Hela-S3	cervix:	n/a	n/a
14	BRCA1	chr15:53003829-53003910	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr15:53025415-53025697	HepG2	liver:	n/a	chr15:53025567-53025578
16	CEBPB	chr15:53012468-53012470	A549	lung:	n/a	n/a
17	CEBPB	chr15:53001361-53001671	IMR90	lung:	n/a	chr15:53001493-53001504 chr15:53001527-53001538
18	CEBPB	chr15:53037556-53038688	H1-hESC	embryonic stem cell:	n/a	n/a
19	CEBPB	chr15:53012270-53012669	Hela-S3	cervix:	n/a	n/a
20	CEBPB	chr15:53025447-53025711	HepG2	liver:	n/a	chr15:53025567-53025578
21	CEBPB	chr15:53021130-53021481	IMR90	lung:	n/a	n/a
22	CEBPB	chr15:53025384-53025753	HepG2	liver:	n/a	chr15:53025567-53025578
23	CEBPB	chr15:53001333-53001688	Hela-S3	cervix:	n/a	chr15:53001493-53001504 chr15:53001527-53001538
24	CEBPB	chr15:53025372-53025801	HepG2	liver:	n/a	chr15:53025567-53025578
25	CEBPB	chr15:53015982-53016146	H1-hESC	embryonic stem cell:	n/a	n/a
26	CEBPB	chr15:53021098-53021506	Hela-S3	cervix:	n/a	n/a
27	CEBPB	chr15:53025408-53025729	K562	blood:	n/a	chr15:53025567-53025578
28	CEBPB	chr15:53007378-53007639	HepG2	liver:	n/a	n/a
29	CEBPB	chr15:53027739-53028160	A549	lung:	n/a	n/a
30	CEBPB	chr15:53015920-53016153	A549	lung:	n/a	n/a
31	CEBPB	chr15:53025362-53025763	Hela-S3	cervix:	n/a	chr15:53025567-53025578
32	CEBPB	chr15:53001375-53001589	HepG2	liver:	n/a	chr15:53001493-53001504 chr15:53001527-53001538
33	CEBPB	chr15:53001315-53001704	HepG2	liver:	n/a	chr15:53001493-53001504 chr15:53001527-53001538
34	CEBPD	chr15:53025449-53025682	HepG2	liver:	n/a	chr15:53025568-53025579
35	CHD1	chr15:53038327-53038859	H1-hESC	embryonic stem cell:	n/a	n/a
36	CHD1	chr15:53037438-53038113	H1-hESC	embryonic stem cell:	n/a	n/a
37	CHD2	chr15:53037424-53038682	H1-hESC	embryonic stem cell:	n/a	n/a
38	CREB1	chr15:53037567-53038030	H1-hESC	embryonic stem cell:	n/a	n/a
39	CREB1	chr15:53037441-53038000	H1-hESC	embryonic stem cell:	n/a	n/a
40	CTBP2	chr15:53037467-53038638	H1-hESC	embryonic stem cell:	n/a	n/a
41	CTCF	chr15:53027760-53027910	BE2_C	brain:	n/a	chr15:53027866-53027879 chr15:53027859-53027880 chr15:53027865-53027881 chr15:53027864-53027882
42	CTCF	chr15:53027800-53027950	HAc	cerebellar:	n/a	chr15:53027866-53027879 chr15:53027859-53027880 chr15:53027865-53027881 chr15:53027864-53027882
43	CTCF	chr15:53027820-53027970	GM06990	blood:	n/a	chr15:53027866-53027879 chr15:53027859-53027880 chr15:53027865-53027881 chr15:53027864-53027882
44	CTCF	chr15:53027680-53027830	WI-38	lung:	n/a	n/a
45	CTCF	chr15:53027760-53027975	A549	lung:	n/a	chr15:53027866-53027879 chr15:53027859-53027880 chr15:53027865-53027881 chr15:53027864-53027882
46	CTCF	chr15:53027800-53027950	HCPEpiC	choroid plexus:	n/a	chr15:53027866-53027879 chr15:53027859-53027880 chr15:53027865-53027881 chr15:53027864-53027882
47	CTCF	chr15:53027820-53027970	HepG2	liver:	n/a	chr15:53027866-53027879 chr15:53027859-53027880 chr15:53027865-53027881 chr15:53027864-53027882
48	CTCF	chr15:53010240-53010390	HepG2	liver:	n/a	n/a
49	CTCF	chr15:53027720-53027870	HFF-Myc	foreskin:	n/a	n/a
50	CTCF	chr15:53027820-53027970	SK-N-SH_RA	brain:	n/a	chr15:53027866-53027879 chr15:53027859-53027880 chr15:53027865-53027881 chr15:53027864-53027882

No.	Distal block	Cell Line	Cell type
1	chr15:53020023..53021825-chr15:53025584..53028001,2	MCF-7	breast:
2	chr15:52820704..52821409-chr15:53027435..53028340,2	K562	blood:
3	chr15:53001338..53004194-chr15:53026134..53027960,2	MCF-7	breast:
4	chr15:52844953..52847640-chr15:53010163..53013098,2	MCF-7	breast:
5	chr15:52979304..52981911-chr15:53011644..53013861,2	MCF-7	breast:
6	chr15:52967780..52973455-chr15:53015921..53024493,22	MCF-7	breast:
7	chr15:53006205..53008987-chr15:53009449..53012016,3	MCF-7	breast:
8	chr15:53006205..53008987-chr15:53009449..53012016,3	MCF-7	breast:
9	chr15:52970614..52972574-chr15:53011299..53014236,2	MCF-7	breast:
10	chr15:53020023..53021825-chr15:53025584..53028001,2	MCF-7	breast:
11	chr15:52969340..52972976-chr15:53024542..53030044,12	MCF-7	breast:
12	chr15:53017085..53018702-chr15:53021319..53022831,2	MCF-7	breast:
13	chr15:52623345..52624286-chr15:53022394..53023020,2	MCF-7	breast:
14	chr15:53020211..53022742-chr15:53022811..53024880,2	MCF-7	breast:
15	chr15:52849763..52852458-chr15:53021230..53022756,2	MCF-7	breast:
16	chr15:53008460..53014321-chr15:53016290..53019599,5	MCF-7	breast:
17	chr15:52587244..52588799-chr15:53018696..53021344,2	MCF-7	breast:
18	chr15:52967401..52973659-chr15:53000765..53004676,11	MCF-7	breast:
19	chr15:52973784..52977367-chr15:53024530..53026901,4	MCF-7	breast:
20	chr15:53017085..53018702-chr15:53021319..53022831,2	MCF-7	breast:
21	chr15:53014375..53016603-chr15:53017308..53019885,2	MCF-7	breast:
22	chr15:52628155..52629955-chr15:53015410..53018106,2	MCF-7	breast:
23	chr15:52978223..52981172-chr15:53005234..53007666,2	MCF-7	breast:
24	chr15:53001798..53003547-chr15:53015558..53017626,2	MCF-7	breast:
25	chr15:52548200..52549159-chr15:53027337..53028329,9	MCF-7	breast:
26	chr15:52969966..52973260-chr15:53007866..53011792,4	MCF-7	breast:
27	chr15:52819938..52821534-chr15:53026653..53028952,2	MCF-7	breast:
28	chr15:53022444..53024405-chr15:53025609..53027744,2	MCF-7	breast:
29	chr15:52942373..52946105-chr15:53022429..53026141,4	MCF-7	breast:
30	chr15:53014375..53016603-chr15:53017308..53019885,2	MCF-7	breast:
31	chr15:52966586..52968208-chr15:53018199..53019999,2	MCF-7	breast:
32	chr15:52965949..52968646-chr15:53025332..53028243,3	MCF-7	breast:
33	chr15:53002359..53006038-chr15:53007315..53009805,4	K562	blood:
34	chr15:53020211..53022742-chr15:53022811..53024880,2	MCF-7	breast:
35	chr15:52509089..52509941-chr15:53027516..53028325,2	MCF-7	breast:
36	chr15:52888619..52891451-chr15:53020250..53023070,2	MCF-7	breast:
37	chr15:52970778..52973073-chr15:53012277..53014291,2	MCF-7	breast:
38	chr15:52623273..52624277-chr15:53027279..53028330,7	MCF-7	breast:
39	chr15:52508008..52509939-chr15:53026331..53028847,2	MCF-7	breast:
40	chr15:52991504..52994033-chr15:53002922..53004759,2	MCF-7	breast:
41	chr15:52968697..52973342-chr15:53018163..53028590,24	MCF-7	breast:
42	chr15:53038140..53039640-chr6:164665968..164668696,2	K562	blood:
43	chr15:52860064..52861646-chr15:53023947..53025473,2	MCF-7	breast:
44	chr15:52548183..52549192-chr15:53027141..53028320,9	K562	blood:
45	chr15:52548546..52549086-chr15:53027357..53028249,2	MCF-7	breast:
46	chr15:52998097..53002621-chr15:53002876..53006188,5	K562	blood:
47	chr15:52623157..52624688-chr15:53027206..53029012,2	MCF-7	breast:
48	chr15:53022444..53024405-chr15:53025609..53027744,2	MCF-7	breast:
49	chr15:52970779..52973636-chr15:53016610..53018142,2	MCF-7	breast:
50	chr15:52509083..52509697-chr15:53027309..53027962,2	MCF-7	breast:

Variant related genes	Relation type
FAM214A	TF binding region
ENSG00000128989	chromatin interactions
ENSG00000128833	chromatin interactions
ENSG00000197535	chromatin interactions
ENSG00000047346	chromatin interactions

Extended variants
information (count: 1542 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:1542 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2414178	chr15:53001538-53001539	Active TSS Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs150418245	chr15:53001555-53001556	Active TSS Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs138405910	chr15:53001560-53001561	Active TSS Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs578016857	chr15:53001625-53001626	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs369723124	chr15:53001673-53001674	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs116252560	chr15:53001711-53001712	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs534603887	chr15:53001728-53001729	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs572451965	chr15:53001736-53001737	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs73409651	chr15:53001755-53001756	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs182237883	chr15:53001760-53001761	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs576206098	chr15:53001797-53001798	Active TSS Flanking Active TSS Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs147252233	chr15:53001843-53001844	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs574082405	chr15:53001897-53001898	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs140592028	chr15:53001921-53001922	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs187581582	chr15:53001922-53001923	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs149334365	chr15:53001924-53001925	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs144546951	chr15:53001958-53001959	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs529625597	chr15:53001990-53001991	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs115056261	chr15:53002001-53002002	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs567944242	chr15:53002024-53002025	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs375686616	chr15:53002034-53002035	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs550314980	chr15:53002068-53002069	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs148443676	chr15:53002130-53002131	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs142622877	chr15:53002136-53002137	Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs554295368	chr15:53002204-53002205	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs146444559	chr15:53002230-53002231	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs139877565	chr15:53002243-53002244	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs143142016	chr15:53002285-53002286	Flanking Active TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs74515928	chr15:53002427-53002428	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs192966991	chr15:53002539-53002540	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs28677029	chr15:53002552-53002553	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs561583170	chr15:53002570-53002571	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs528132740	chr15:53002613-53002614	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs557217081	chr15:53002632-53002633	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs576606608	chr15:53002658-53002659	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs60796630	chr15:53002670-53002671	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs6493574	chr15:53002685-53002686	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
38	rs371266187	chr15:53002688-53002689	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs544031971	chr15:53002690-53002691	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs529687534	chr15:53002744-53002745	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs7167235	chr15:53002762-53002763	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs184682912	chr15:53002801-53002802	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs73409655	chr15:53002845-53002846	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs550185948	chr15:53002848-53002849	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs571907848	chr15:53002870-53002871	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs532536486	chr15:53002877-53002878	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs532746218	chr15:53002891-53002892	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs547960182	chr15:53002903-53002904	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs566134201	chr15:53002920-53002921	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs536257769	chr15:53002925-53002926	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Colorectal cancer	16774939	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	21785460	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	17053054	CNVD
Breast cancer	22032731	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Hirschsprung''s Disease	21712996	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Cancer	21129771	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Abnormal phenotypes	18644119	CNVD
Cancer	16751803	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Myelofibrosis	22110671	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute monocytic leukemia	16498392	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Glioma	20126413	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:385 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:52995800-53001600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr15:52998800-53001600	Weak transcription	NHEK	skin
3	chr15:52998800-53002200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr15:53000800-53001800	Weak transcription	Adipose Nuclei	Adipose
5	chr15:53000800-53002000	Flanking Active TSS	Primary B cells from cord blood	blood
6	chr15:53001000-53001600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
7	chr15:53001000-53001600	Enhancers	Rectal Mucosa Donor 31	rectum
8	chr15:53001000-53001800	Enhancers	GM12878-XiMat	blood
9	chr15:53001000-53002200	Flanking Active TSS	Primary B cells from peripheral blood	blood
10	chr15:53001200-53001600	Active TSS	Liver	Liver
11	chr15:53001200-53001800	Flanking Active TSS	Duodenum Mucosa	Duodenum
12	chr15:53001200-53002000	Active TSS	Fetal Intestine Large	intestine
13	chr15:53001200-53002000	Active TSS	Fetal Intestine Small	intestine
14	chr15:53001200-53002400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
15	chr15:53001200-53002600	Weak transcription	Sigmoid Colon	Sigmoid Colon
16	chr15:53001200-53002800	Flanking Active TSS	HepG2	liver
17	chr15:53001400-53001600	Enhancers	H1 Cell Line	embryonic stem cell
18	chr15:53001400-53001600	Enhancers	H9 Cell Line	embryonic stem cell
19	chr15:53001400-53001600	Enhancers	HUES6 Cell Line	embryonic stem cell
20	chr15:53001400-53001800	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
21	chr15:53001400-53002000	Active TSS	Rectal Mucosa Donor 29	rectum
22	chr15:53001400-53002200	Active TSS	ES-I3 Cell Line	embryonic stem cell
23	chr15:53001400-53002200	Active TSS	HUES48 Cell Line	embryonic stem cell
24	chr15:53001400-53002200	Active TSS	iPS-15b Cell Line	embryonic stem cell
25	chr15:53001600-53001800	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
26	chr15:53001600-53001800	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr15:53001600-53001800	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
28	chr15:53001600-53002000	Active TSS	Primary Natural Killer cells fromperipheralblood	blood
29	chr15:53001600-53002000	Active TSS	Colonic Mucosa	Colon
30	chr15:53001600-53002000	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
31	chr15:53001600-53002200	Flanking Active TSS	H1 Cell Line	embryonic stem cell
32	chr15:53001600-53002200	Active TSS	H9 Cell Line	embryonic stem cell
33	chr15:53001600-53002200	Active TSS	iPS-20b Cell Line	embryonic stem cell
34	chr15:53001600-53002200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr15:53001600-53002400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
36	chr15:53001600-53002400	Flanking Active TSS	Liver	Liver
37	chr15:53001600-53002800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
38	chr15:53001600-53003200	Enhancers	NHEK	skin
39	chr15:53001800-53002000	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
40	chr15:53001800-53002000	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
41	chr15:53001800-53002000	Enhancers	Esophagus	oesophagus
42	chr15:53001800-53002200	Active TSS	HUES64 Cell Line	embryonic stem cell
43	chr15:53001800-53002200	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
44	chr15:53001800-53002200	Active TSS	iPS-18 Cell Line	embryonic stem cell
45	chr15:53001800-53002200	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
46	chr15:53001800-53002200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
47	chr15:53001800-53002200	Active TSS	Duodenum Mucosa	Duodenum
48	chr15:53001800-53002200	Enhancers	Hela-S3	cervix
49	chr15:53001800-53002400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
50	chr15:53001800-53002400	Enhancers	Gastric	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links